Picture Berlin Partner Special Topic Well-trained Professionals 650x100px

Person › Details

Paul van der Horst (Agomab Therapeutics N.V.)

van der Horst, Paul (AgomAb Therapeutics 202103– CBO before Galapagos + Kempen & Co)

	Organisation	Agomab Therapeutics N.V.
	Group	Agomab Therapeutics (Group)
	Former/major organisation	Galapagos N.V. (Euronext + Nasdaq: GLPG)
	Group	Galapagos (Group)
	Product	AGMB-101 (HGF-mimetic agonistic MET receptor antibody, AgomAb)
	Product 2	drug discovery services

Record changed: 2023-04-03

Picture Berlin Partner Special Topic HealthCapital Berlin-Brandenburg 650x200px

More documents for Paul van der Horst

[1] Molecure S.A.. (3/30/23). "Press Release: Molecure Announces Full Year Financial 2022 Results – a Year of Significant Progress". Warsaw....
[2] Agomab Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent....
[3] Galapagos N.V.. (1/15/20). "Press Release: Fibrocor and Galapagos Sign Expanded Collaboration in Fibrosis". Mechelen & Toronto....
[4] Galapagos N.V.. (9/13/18). "Press Release: Galapagos Raises $300 Million Gross Proceeds in a U.S. Public Offering". Mechelen....
[5] Galapagos N.V.. (9/12/18). "Press Release: Galapagos Announces Launch of Proposed Public Offering". Mechelen....
[6] Galapagos N.V.. (4/21/17). "Press Release: Galapagos Announces Capital Increase". Mechelen....
[7] Galapagos N.V.. (4/21/17). "Press Release: Galapagos Announces Closing of Public Offering of American Depositary Shares for Gross Proceeds of €363.9 Million". Mechelen....
[8] Galapagos N.V.. (4/18/17). "Press Release: Galapagos Raises $338 Million Gross Proceeds in a U.S. Public Offering". Mechelen....
[9] Galapagos N.V.. (4/17/17). "Press Release: Galapagos Announces Launch of Proposed Public Offering". Mechelen....
[10] Galapagos N.V.. (3/10/17). "Press Release: New Phase 2 Studies with Filgotinib in Small Bowel and Fistulizing Crohn’s disease". Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]